UPC (Universe Pharmaceuticals) Interest Expense : $-0.16 Mil (TTM As of Sep. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Universe Pharmaceuticals Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Universe Pharmaceuticals's interest expense for the six months ended in Sep. 2023 was $ -0.08 Mil. Its interest expense for the trailing twelve months (TTM) ended in Sep. 2023 was $-0.16 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Universe Pharmaceuticals's Operating Income for the six months ended in Sep. 2023 was $ -4.12 Mil. Universe Pharmaceuticals's Interest Expense for the six months ended in Sep. 2023 was $ -0.08 Mil. Universe Pharmaceuticals did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Universe Pharmaceuticals Interest Expense Historical Data

The historical data trend for Universe Pharmaceuticals's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Universe Pharmaceuticals Interest Expense Chart

Universe Pharmaceuticals Annual Data

Trend

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Interest Expense

Get a 7-Day Free Trial

-0.13

-0.12

-0.10

-0.16

Universe Pharmaceuticals Semi-Annual Data
	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
Interest Expense	Get a 7-Day Free Trial						-0.06	-0.09	-0.07	-0.08	-0.08

Universe Pharmaceuticals Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Sep. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-0.16 Mil.

Universe Pharmaceuticals (NAS:UPC) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Universe Pharmaceuticals's Interest Expense for the six months ended in Sep. 2023 was $-0.08 Mil. Its Operating Income for the six months ended in Sep. 2023 was $-4.12 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Sep. 2023 was $0.00 Mil.

Universe Pharmaceuticals's Interest Coverage for the quarter that ended in Sep. 2023 is calculated as

Universe Pharmaceuticals did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

Universe Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Universe Pharmaceuticals Inc (NAS:UPC) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

265 Jingjiu Avenue, Economic & Technological Development Zone, Jinggangshan, Jiangxi, Ji’an, CHN

Website

http://www.universe-pharmacy.com

Universe Pharmaceuticals Inc is a pharmaceutical company specializing in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivatives products targeting the elderly with the goal of addressing their physical conditions in the ageing process and promoting their general well-being. The company also sells biomedical drugs medical instruments, Traditional Chinese Medicine Pieces, and dietary supplements manufactured by third-party pharmaceutical companies. Its products are under two categories namely treatment and relief for common chronic health conditions in the elderly designed to achieve physical wellness and longevity (Chronic Condition Treatments), and cold and flu medications.